Trials / Conditions / Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive
7 registered clinical trials studyying Neuroectodermal Tumors, Primitive — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms NCT04541082 | Jazz Pharmaceuticals | Phase 1 |
| Recruiting | HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors NCT03911388 | M.D. Anderson Cancer Center | Phase 1 |
| Terminated | Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) NCT02624388 | University of Virginia | Phase 2 |
| Completed | NAC to Prevent Cisplatin-induced Hearing Loss NCT02094625 | Children's Hospital Los Angeles | Phase 1 |
| Terminated | Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CN NCT02332889 | University of Louisville | Phase 1 / Phase 2 |
| Completed | Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors NCT01661400 | Washington University School of Medicine | Phase 1 |
| Unknown | High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood NCT00180791 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 2 |